DAVID BRONAUGH: Open Payments
NPI 1447358254 · SNELLVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,631 in 81 payments from 27 companies in 2025. Trend: 2023 $1,553 · 2024 $1,784 · 2025 $1,631
Food & beverage: $1,631
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $341 |
| Sumitomo Pharma America, Inc. | 20 | $255 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $160 |
| AstraZeneca Pharmaceuticals LP | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Inspire Medical Systems, Inc. | 3 | $74 |
| ABBVIE INC. | 3 | $65 |
| Astellas Pharma US Inc | 3 | $62 |
| Novo Nordisk Inc | 3 | $57 |
| PFIZER INC. | 2 | $44 |
Products named: GEMTESA, Kerendia, REXULTI, AIRSUPRA, OTEZLA, INSPIRE, Veozah, EVENITY.
Industry payments across GA — which companies pay providers there.
